Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms

• 收藏
• 分享

专利权人:

SANOFI

发明人:

MORARIU RODICA

申请号：

NZ61801212

公开号：

NZ618012A

申请日:

2012.05.16

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

Discloses a use of an anti-CD19 maytansinoid immunoconjugate in the manufacture of a medicament for the treatment of leukemia or lymphoma wherein said medicament is formulated so as to achieve an initial dose of about 55 mg/m² and a plurality of subsequent doses of about 55 mg/m², wherein the subsequent doses are separated in time from each other by about one week.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/